Scott Plotkin
Director/Miembro de la Junta en Children's Tumor Foundation .
Perfil
Scott Plotkin is the founder of NF2 Therapeutics, Inc. He is currently the Director of the Neurofibromatosis Clinic at The General Hospital Corp.
and the Director of the Children's Tumor Foundation.
Cargos activos de Scott Plotkin
| Empresas | Cargo | Inicio |
|---|---|---|
The General Hospital Corp.
 The General Hospital Corp. Hospital/Nursing ManagementHealth Services The General Hospital Corp. provides healthcare services. It offers diagnostic and therapeutic are in every specialty and subspecialty of medicine and surgery. The firm's care center provides cancer, digestive disorders, heart disease, transplantation and vascular medicine services. The company was founded in 1811 and is headquartered in Boston, MA. | Corporate Officer/Principal | - |
| Children's Tumor Foundation | Director/Miembro de la Junta | - |
Antiguos cargos conocidos de Scott Plotkin.
| Empresas | Cargo | Fin |
|---|---|---|
NF2 Therapeutics, Inc.
 NF2 Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services NF2 Therapeutics, Inc. develops therapies. The American company was founded by Michael Wootton, Mark P de Souza, Scott Plotkin. Michael Wootton has been the CEO since incorporation. | Fundador | - |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 3 |
|---|---|
The General Hospital Corp.
The General Hospital Corp. Hospital/Nursing ManagementHealth Services The General Hospital Corp. provides healthcare services. It offers diagnostic and therapeutic are in every specialty and subspecialty of medicine and surgery. The firm's care center provides cancer, digestive disorders, heart disease, transplantation and vascular medicine services. The company was founded in 1811 and is headquartered in Boston, MA. | Health Services |
| Children's Tumor Foundation | Miscellaneous |
NF2 Therapeutics, Inc.
NF2 Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services NF2 Therapeutics, Inc. develops therapies. The American company was founded by Michael Wootton, Mark P de Souza, Scott Plotkin. Michael Wootton has been the CEO since incorporation. | Commercial Services |
- Bolsa de valores
- Insiders
- Scott Plotkin
